ArticleHealth science reports2025
Osteoarticular Complications of Sickle Cell Disease in Bukavu: A Retrospective Multicenter Cross-Sectional Study.
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aim: This study aimed to investigate the epidemiological, clinical, and therapeutic aspects of osteoarticular complications in patients with sickle cell disease in Bukavu. Methods: We conducted a multicenter cross-sectional study over 5 years, focusing on 31 patients with sickle cell disease who were admitted for osteoarticular complications in Bukavu. Data were collected from medical records and analyzed with the Statistical Package for Social Science 26 (IBM, SPSS 26). Results: We recorded 31 (6.07%) sickle cell patients with osteoarticular complications, with a mean age of 10.5 ± 5.6 years (extremes: 2-30 years). Pain, fever, and functional impotence were the most frequent reasons for consultation with 9 (29.03%) patients. Septic arthritis was the most common complication in 10 (32.26%), followed by osteonecrosis of the femoral head in 8 (25.81%), chronic osteomyelitis in 7 (22.58%) cases, and acute osteomyelitis in 4 (12.70%) patients. The femur was the most affected bone. Articular complications predominantly impacted larger joints, with the knee joint experiencing the highest rate of damage, occurring in 38.71% of cases. Treatment, including medical and surgical methods, was provided in 16 cases (51.6%). Complete healing without residual effects was achieved in 22 patients (70.96%). Conclusion: The osteoarticular complications of sickle cell disease are frequent in the city of Bukavu, and regular monitoring and early consultation would enable early diagnosis and management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.